A systems biology examination of the human female genital tract shows compartmentalization of immune factor expression

Journal of Virology

Volumn 87, Issue 9, 2013, Pages 5141-5150

  Burgener, Adam ^a,b   Tjernlund, Annelie ^c   Kaldensjo, Tove ^c   Abou, Max ^b   McCorrister, Stuart ^d   Westmacott, Garrett R ^d   Mogk, Kenzie ^a,b   Ambrose, Emma ^a,b   Broliden, Kristina ^c   Balla, Blake ^a,b,d,e  

^a UNIVERSITY OF MANITOBA   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c KAROLINSKA INSTITUTE   (Sweden)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^e UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIINFECTIVE AGENT; COMPLEMENT; IMMUNOGLOBULIN; LIVER X RECEPTOR; PROTEINASE INHIBITOR; RETINOID X RECEPTOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; FEMALE GENITAL SYSTEM; GLUCONEOGENESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MASS SPECTROMETRY; MICROENVIRONMENT; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEOMICS; QUALITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TISSUE DISTRIBUTION; UTERINE CERVIX; UTERINE ECTOCERVIX; UTERINE ENDOCERVIX; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADULT; FEMALE; GENITALIA, FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; PROTEINS; TRANSCRIPTOME;

EID: 84876301821     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03347-12     Document Type: Article

References (51)

1. UNAIDS. 2011. Global report: UNAIDS report on the global AIDS epidemic, 2010. Joint United Nations Programme on HIV/AIDS, New York, NY. http://www.unaids.org/documents/20101123_globalreport_em.pdf.
2. Valore EV, Park CH, Igreti SL, Ganz T. 2002. Antimicrobial components of vaginal fluid. Am. J. Obstet. Gynecol. 187:561-568.
3. Wira CR, Patel MV, Ghosh M, Mukura L, Fahey JV. 2011. Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am. J. Reprod. Immunol. 65:196-211.
4. Ghosh M, Fahey JV, Shen Z, Lahey T, Cu-Uvin S, Wu Z, Mayer K, Wright PF, Kappes JC, Ochsenbauer C, Wira CR. 2010. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and-negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS One 5:e11366. doi:10.1371/journal.pone.0011366.
5. Hur EM, Patel SN, Shimizu S, Rao DS, Gnanapragasam PN, An DS, Yang L, Baltimore D. 2012. Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice. Blood 120:4571-4582.
6. Mascola JR, Stiegler G, VanCott TC, Katinger H, Carpenter CB, Hanson CE, Beary H, Hayes D, Frankel SS, Birx DL, Lewis MG. 2000. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6:207-210.
7. Carroll MC. 2004. The complement system in regulation of adaptive immunity. Nat. Immunol. 5:981-986.
8. Yu Q, Yu R, Qin X. 2010. The good and evil of complement activation in HIV-1 infection. Cell. Mol. Immunol. 7:334-340.
9. Devito C, Broliden K, Kaul R, Svensson L, Johansen K, Kiama P, Kimani J, Lopalco L, Piconi S, Bwayo JJ, Plummer F, Clerici M, Hinkula J. 2000. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J. Immunol. 165:5170-5176.
10. Hirbod T, Kaul R, Reichard C, Kimani J, Ngugi E, Bwayo JJ, Nagelkerke N, Hasselrot K, Li B, Moses S, MacDonald KS, Broliden K. 2008. HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. AIDS 22:727-735.
11. Tudor D, Derrien M, Diomede L, Drillet AS, Houimel M, Moog C, Reynes JM, Lopalco L, Bomsel M. 2009. HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis. Mucosal Immunol. 2:412-426.
12. Burgener A, Boutilier J, Wachihi C, Kimani J, Carpenter M, Westmacott G, Cheng K, Ball TB, Plummer F. 2008. Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers. J. Proteome Res. 7:4446-4454.
13. Burgener A, Rahman S, Ahmad R, Lajoie J, Ramdahin S, Mesa C, Brunet S, Wachihi C, Kimani J, Fowke K, Carr S, Plummer F, Ball TB. 2011. Comprehensive proteomic study identifies serpin and cystatin antiproteases as novel correlates of HIV-1 resistance in the cervicovaginal mucosa of female sex workers. J. Proteome Res. 10:5139-5149.
14. Iqbal SM, Ball TB, Levinson P, Maranan L, Jaoko W, Wachihi C, Pak BJ, Podust VN, Broliden K, Hirbod T, Kaul R, Plummer FA. 2009. Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition. AIDS 23:1669-1677.
15. Burgener A, Mogk K, Westmacott G, Plummer F, Ball B, Broliden K, Hasselrot K. 2012. Salivary basic proline-rich proteins are elevated in HIV-exposed seronegative men who have sex with men. AIDS 26:1857-1867.
16. Eisen MB, Spellman PT, Brown PO, Botstein D. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 95:14863-14868.
17. Hirbod T, Bailey RC, Agot K, Moses S, Ndinya-Achola J, Murugu R, Andersson J, Nilsson J, Broliden K. 2010. Abundant expression of HIV target cells and C-type lectin receptors in the foreskin tissue of young Kenyan men. Am. J. Pathol. 176:2798-2805.
18. Hirbod T, Kaldensjo T, Lopalco L, Klareskog E, Andersson S, Uberti-Foppa C, Ferrari D, Manghi M, Andersson J, Lore K, Broliden K. 2009. Abundant and superficial expression of C-type lectin receptors in ectocervix of women at risk of HIV infection. J. Acquir. Immune Defic. Syndr. 51:239-247.
19. Valledor AF. 2005. The innate immune response under the control of the LXR pathway. Immunobiology 210:127-132.
20. Yoo JY, Desiderio S. 2003. Innate and acquired immunity intersect in a global view of the acute-phase response. Proc. Natl. Acad. Sci. U. S. A. 100:1157-1162.
21. Etienne-Manneville S, Hall A. 2002. Rho GTPases in cell biology. Nature 420:629-635.
22. Rai T, Mosoian A, Resh MD. 2010. Annexin 2 is not required for human immunodeficiency virus type 1 particle production but plays a cell typedependent role in regulating infectivity. J. Virol. 84:9783-9792.
23. Li G, Dziuba N, Friedrich B, Murray JL, Ferguson MR. 2011. A postentry role for CD63 in early HIV-1 replication. Virology 412:315-324.
24. Shattock RJ, Rizzardi GP, Hayes P, Griffin GE. 1996. Engagement of adhesion molecules (CD18, CD11a, CD45, CD44, and CD58) enhances human immunodeficiency virus type 1 replication in monocytic cells through a tumor necrosis factor-modulated pathway. J. Infect. Dis. 174:54-62.
25. Cooper J, Liu L, Woodruff EA, Taylor HE, Goodwin JS, D'Aquila RT, Spearman P, Hildreth JE, Dong X. 2011. Filamin A protein interacts with human immunodeficiency virus type 1 Gag protein and contributes to productive particle assembly. J. Biol. Chem. 286:28498-28510.
26. Wang XM, Nadeau PE, Lin S, Abbott JR, Mergia A. 2011. Caveolin 1 inhibits HIV replication by transcriptional repression mediated through NF-kappaB. J. Virol. 85:5483-5493.
27. Abbas W, Dichamp I, Herbein G. 2012. The HIV-1 Nef protein interacts with two components of the 40S small ribosomal subunit, the RPS10 protein and the 18S rRNA. Virol. J. 9:103. doi:10.1186/1743-422X-9-103.
28. Reddy TR, Suhasini M, Xu W, Yeh LY, Yang JP, Wu J, Artzt K, Wong-Staal F. 2002. A role for KH domain proteins (Sam68-like mammalian proteins and quaking proteins) in the post-transcriptional regulation of HIV replication. J. Biol. Chem. 277:5778-5784.
29. Terada Y, Yasuda Y. 2006. Human immunodeficiency virus type 1 Vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145. Mol. Cell. Biol. 26:8149-8158.
30. Devito C, Hinkula J, Kaul R, Lopalco L, Bwayo JJ, Plummer F, Clerici M, Broliden K. 2000. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS 14:1917-1920.
31. Ghosh M, Shen Z, Fahey JV, Cu-Uvin S, Mayer K, Wira CR. 2010. Trappin-2/elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract. Immunology 129:207-219.
32. Shapiro L, Pott GB, Ralston AH. 2001. Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1. FASEB J. 15:115-122.
33. Pudney J, Quayle AJ, Anderson DJ. 2005. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol. Reprod. 73:1253-1263.
34. Kramer HB, Lavender KJ, Qin L, Stacey AR, Liu MK, di Gleria K, Simmons A, Gasper-Smith N, Haynes BF, McMichael AJ, Borrow P, Kessler BM. 2010. Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection. PLoS Pathog. 6:e1000893. doi:10.1371/journal.ppat.1000893.
35. Liu Y, Belkina NV, Shaw S. 2009. HIV infection of T cells: actin-in and actin-out. Sci. Signal. 2:pe23. doi:10.1126/scisignal.266pe23.
36. Hirbod T, Kaldensjo T, Broliden K. 2011. In situ distribution of HIVbinding CCR5 and C-type lectin receptors in the human endocervical mucosa. PLoS One 6:e25551. doi:10.1371/journal.pone.0025551.
37. Kaldensjo T, Petersson P, Tolf A, Morgan G, Broliden K, Hirbod T. 2011. Detection of intraepithelial and stromal Langerin and CCR5 positive cells in the human endometrium: potential targets for HIV infection. PLoS One 6:e21344. doi:10.1371/journal.pone.0021344.
38. Howell AL, Edkins RD, Rier SE, Yeaman GR, Stern JE, Fanger MW, Wira CR. 1997. Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract. J. Virol. 71:3498-3506.
39. Yeaman GR, Asin S, Weldon S, Demian DJ, Collins JE, Gonzalez JL, Wira CR, Fanger MW, Howell AL. 2004. Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology 113:524-533.
40. Kopitar-Jerala N. 2006. The role of cystatins in cells of the immune system. FEBS Lett. 580:6295-6301.
41. Mangan MS, Kaiserman D, Bird PI. 2008. The role of serpins in vertebrate immunity. Tissue Antigens 72:1-10.
42. Pott GB, Chan ED, Dinarello CA, Shapiro L. 2009. Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J. Leukoc. Biol. 85:886-895.
43. Challacombe SJ, Sweet SP. 2002. Oral mucosal immunity and HIV infection: current status. Oral Dis. 8(Suppl 2):55-62.
44. Whitney JB, Asmal M, Geiben-Lynn R. 2011. Serpin induced antiviral activity of prostaglandin synthetase-2 against HIV-1 replication. PLoS One 6:e18589. doi:10.1371/journal.pone.0018589.
45. Huber M, Fischer M, Misselwitz B, Manrique A, Kuster H, Niederost B, Weber R, von Wyl V, Gunthard HF, Trkola A. 2006. Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection. PLoS Med. 3:e441. doi:10.1371 /journal.pmed.0030441.
46. Stoiber H, Pruenster M, Ammann CG, Dierich MP. 2005. Complementopsonized HIV: the free rider on its way to infection. Mol. Immunol. 42:153-160.
47. Tjomsland V, Ellegard R, Che K, Hinkula J, Lifson JD, Larsson M. 2011. Complement opsonization of HIV-1 enhances the uptake by dendritic cells and involves the endocytic lectin and integrin receptor families. PLoS One 6:e23542. doi:10.1371/journal.pone.0023542.
48. Baba TW, Liska V, Hofmann-Lehmann R, Vlasak J, Xu W, Ayehunie S, Cavacini LA, Posner MR, Katinger H, Stiegler G, Bernacky BJ, Rizvi TA, Schmidt R, Hill LR, Keeling ME, Lu Y, Wright JE, Chou TC, Ruprecht RM. 2000. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat. Med. 6:200-206.
49. Bomsel M, Tudor D, Drillet AS, Alfsen A, Ganor Y, Roger MG, Mouz N, Amacker M, Chalifour A, Diomede L, Devillier G, Cong Z, Wei Q, Gao H, Qin C, Yang GB, Zurbriggen R, Lopalco L, Fleury S. 2011. Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity 34:269-280.
50. Tomaras GD, Yates NL, Liu P, Qin L, Fouda GG, Chavez LL, Decamp AC, Parks RJ, Ashley VC, Lucas JT, Cohen M, Eron J, Hicks CB, Liao HX, Self SG, Landucci G, Forthal DN, Weinhold KJ, Keele BF, Hahn BH, Greenberg ML, Morris L, Karim SS, Blattner WA, Montefiori DC, Shaw GM, Perelson AS, Haynes BF. 2008. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulinM( IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J. Virol. 82:12449-12463.
51. Choi R, Levinson P, Guthrie B, Lohman-Payne B, Bosire R, Liu A, Hirbod T, Kiarie J, Overbaugh J, John-Stewart G, Broliden K, Farquhar C. 2012. Cervicovaginal HIV-1 neutralizing immunoglobulin A detected among HIV-1-exposed seronegative female partners in HIV-1-discordant couples. AIDS 26:2155-2163.